CSF3 and neoplasm: Tumor infiltrating Th17 cells and IL-17 induced the expression of granulocyte-colony stimulating factor (G-CSF) leading to immature myeloid cell recruitment into the tumor microenvironment and anti-VEGF therapy resistance through the production of proangiogenic Bv8 by these myeloid cells [31].